Purchase Short-Term Access

Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy: A Randomized Trial
Nicola A. Hanania, MD, MS; Oral Alpan, MD; Daniel L. Hamilos, MD; John J. Condemi, MD; Irmarie Reyes-Rivera, PhD; Jin Zhu, PhD; Karin E. Rosen, MD, PhD; Mark D. Eisner, MD, MPH; Dennis A. Wong, MD; William Busse, MD
Annals of Internal Medicine 2011;154:573-582. doi:10.7326/0003-4819-154-9-201105030-00002

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.